Abstract

Background: Molecular genetic alterations with prognostic significance have been described in childhood acute myeloid leukemia (AML). The aim of this study was to establish cost-effective techniques to detect mutations of FMS-like tyrosine kinase 3 (FLT3), nucleophosmin 1 (NPM1), and a partial tandem duplication within the mixed-lineage leukemia (MLL-PTD) genes in childhood AML.Procedure: Ninety-nine children with newly diagnosed AML were included in this study. We developed a fluorescent dye SYTO-82 based high-resolution melting (HRM) curve analysis to detect FLT3 internal tandem duplication (FLT3-ITD), FLT3 tyrosine kinase domain (FLT3-TKD), and NPM1 mutations. MLL-PTD was screened by real-time quantitative PCR.Results: The HRM methodology correlated well with gold standard Sanger sequencing with less cost. Among the 99 patients studied, the FLT3-ITD mutation was associated with significantly worse event-free survival (EFS). Patients with the NPM1 mutation had significantly better EFS and overall survival. However, HRM was not sensitive enough for minimal residual disease monitoring.Conclusion: High-resolution melting was a rapid and efficient method for screening of FLT3 and NPM1 gene mutations. It was both affordable and accurate, especially in resource underprivileged regions. Our results indicated that HRM could be a useful clinical tool for rapid and cost-effective screening of the FLT3 and NPM1 mutations in AML patients.

Highlights

  • Acute myeloid leukemia (AML) is a group of heterogeneous disease harboring different genetic alterations and with considerable diversity in clinical behavior and prognosis [1,2,3]

  • Molecular genetic alterations with prognostic significance have been described in childhood acute myeloid leukemia (AML).The aim of this study was to establish cost-effective techniques to detect mutations of FMS-like tyrosine kinase 3 (FLT 3), nucleophosmin 1 (NPM1), and a partial tandem duplication within the mixed-lineage leukemia (MLL-Partial tandem duplication (PTD)) genes in childhood AML

  • Among the 99 patients studied, the FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutation was associated with significantly worse event-free survival (EFS)

Read more

Summary

Introduction

Acute myeloid leukemia (AML) is a group of heterogeneous disease harboring different genetic alterations and with considerable diversity in clinical behavior and prognosis [1,2,3]. FMS-like tyrosine kinase receptor (FLT3) internal tandem duplications (ITDs) are caused by the duplication of the exon 14 sequence at juxtamembrane domain, leading to constitutive activation of downstream signaling [16, 17]. Point mutations in codon 835 or 836 of the FLT3 gene tyrosine kinase domain (FLT3-TKD) occur in 3–11% of patients [4,5,6,7, 18, 19], but the prognostic relevance remains to be defined. Molecular genetic alterations with prognostic significance have been described in childhood acute myeloid leukemia (AML).The aim of this study was to establish cost-effective techniques to detect mutations of FMS-like tyrosine kinase 3 (FLT 3), nucleophosmin 1 (NPM1), and a partial tandem duplication within the mixed-lineage leukemia (MLL-PTD) genes in childhood AML

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call